Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organoid-guided therapy in advanced breast cancer
NCT06102824Phase 2Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Oct 2024
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Autologous extrahepatic cholangiocyte organoids in breast cancer, sponsored by Guangdong Provincial People's Hospital. Started Oct 2024; status: recruiting.
02
Drugs
Autologous extrahepatic cholangiocyte organoids
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06102824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06102824.